She spent afternoons taking part in Skat, a card recreation, together with her mom and her mom’s mates, who taught her aphorisms comparable to “if somebody exhibits you who they’re, you need to consider them” or “there’s nothing a tough drink can’t repair.”
“I used to be 12,” Ms. Pelletier mentioned. “They have been seasoned and clever and had been via hell. What they hoped for me was that I might get out and by no means come again.” Which she did. (Although “on actually unhealthy days, I get in my infrared sleeping bag and I drink a martini,” she mentioned. “Gray Goose, very dry with a lemon twist”).
After attending Husson College in Bangor, Maine, Ms. Pelletier labored as a gross sales consultant at G.D. Searle, the pharmaceutical firm that first developed the contraception tablet, now owned by Pfizer. She rose to change into a head of world new enterprise within the girls’s well being division. “Working in pharma taught me easy methods to speak with affect, easy methods to behave, easy methods to current, easy methods to use sure levers, easy methods to learn a room,” she mentioned.
In 2009, she based a nonprofit known as Girl Care World, which centered on reproductive well being world wide. Throughout her time there, in 2013, Ms. Pelletier got here throughout a product known as Amphora, developed by a group of scientists at Rush College in Chicago, and owned by an organization known as EvoMed that was in bother. “They didn’t have the precise technique, they didn’t have the financing, the management,” she mentioned.
Ultimately, the traders in EvoMed separated the ladies’s well being division, created a brand new firm known as Evofem and put Ms. Pelletier in cost. Amphora was later renamed Phexxi (the primary two letters signify pH and the double X is for the intercourse chromosome.) In 2015, she turned the corporate’s C.E.O. Since then, she has led Evofem in elevating $491 million from traders and employed 128 workers.